Insights from 2023 ESMO Asia Annual Meeting

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Insights from 2023 ESMO Asia Annual Meeting

Genitourinary
Gastrointestinal
Lung
Breast
Gynecologic

Playback speed

10 seconds

Final Analysis of a Ph2 Study of Neoadjuvant S-1 + Oxaliplatin in Older Patients With Locally Advanced Gastric Cancer

By Insights from 2023 ESMO Asia Annual Meeting FEATURING Eiji Oki

34 views

February 22, 2024

Comments 0

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Gastrointestinal

Enhancing IO Benefit in Upper-Aerodigestive Malignancies - Leveragin…

Insights from 2023 ESMO Asia Annual Meeting

B. Henick

114 views

Final Analysis of a Ph2 Study of Neoadjuvant S-1 + Oxaliplatin in Ol…

Insights from 2023 ESMO Asia Annual Meeting

E. Oki

34 views

ESMO Asia 2023 Insights: "IMbrave150 Trial - Exploratory Analyses fo…

Insights from 2023 ESMO Asia Annual Meeting

M. Kudo

60 views

Leveraging the Molecular Biology of HCC in Optimising Response to Im…

Insights from 2023 ESMO Asia Annual Meeting

S. L. Chan

38 views

ESMO Asia 2023 Insights: "Lenvatinib vs. Sorafenib 2L Therapy in HCC…

Insights from 2023 ESMO Asia Annual Meeting

M. Persano

71 views

ESMO Asia 2023 Insights: "AEs as Potential Predictive Factors of Act…

Insights from 2023 ESMO Asia Annual Meeting

M. Persano

41 views

ESMO Asia 2023 Insights: "Long-Term Outcomes of Intraoperative Chemo…

Insights from 2023 ESMO Asia Annual Meeting

J. Taieb

131 views

ESMO Asia 2023 Insights: "Past, Present & Future Clinical Management…

Insights from 2023 ESMO Asia Annual Meeting

M. Ikeda

305 views

ESMO Asia 2023 Insights: "Role of IO in Gastric Cancer"

Insights from 2023 ESMO Asia Annual Meeting

S. Rha

189 views

ESMO Asia 2023 Insights: "KEYNOTE-811 Study of Pembro + Trastuzumab …

Insights from 2023 ESMO Asia Annual Meeting

S. Rha

142 views

ESMO Asia 2023 Insights: "Final Results of the RATIONALE-305 Study -…

Insights from 2023 ESMO Asia Annual Meeting

K. Kato

132 views